LEXARIA BIOSCIENCE CORP. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for the quarter ending 2024-05-31 was $2.87K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for the quarter ending 2020-08-31 was $19.03K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for the quarter ending 2020-05-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for the quarter ending 2020-02-29 was $11.00K, a 40.54% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for fiscal 2024 was $2.88K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for fiscal 2021 was $4.02M, a 13270.11% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for fiscal 2020 was $30.03K, a 54.67% decline from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, stock options exercised for fiscal 2019 was $66.25K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-08-31 | $2.88K 10-K · filed 2025-11-28 | |
| 2024-05-31 | $2.87K 10-Q · filed 2025-07-14 | |
| 2021-08-31 | $4.02M 10-K · filed 2022-11-28 | |
| 2020-08-31 | $19.03K 10-Q · filed 2021-07-15 | $30.03K 10-K · filed 2021-11-29 |
| 2020-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | |
| 2020-02-29 | $11.00K 10-Q · filed 2021-07-15 | |
| 2019-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $66.25K 10-K · filed 2020-10-15 |
| 2019-05-31 | $14.75K 10-Q · filed 2020-06-29 | $88.75K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-02-28 | $18.50K 10-Q · filed 2020-06-29 | $406.00K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-11-30 | $33.00K 10-Q · filed 2020-06-29 | $446.20K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-08-31 | $22.50K 10-Q · filed 2019-07-08 | $93.70K 10-Q · filed 2020-01-09 |
| 2018-05-31 | $332.00K 10-Q · filed 2019-07-08 | $415.70K derived: sum of 4 quarters · filed 2019-07-08 |
| 2018-02-28 | $58.70K 10-Q · filed 2019-07-08 | $99.75K derived: sum of 4 quarters · filed 2019-07-08 |
| 2017-11-30 | $12.50K 10-Q · filed 2019-07-08 | $177.26K derived: sum of 4 quarters · filed 2019-07-08 |
| 2017-08-31 | $12.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $177.26K 10-K · filed 2018-11-14 |
| 2017-05-31 | $16.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-14 | |
| 2017-02-28 | $136.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-14 | |
| 2016-11-30 | $12.50K 10-Q · filed 2017-01-13 | |
| 2011-10-31 | $21.25K 10-Q · filed 2012-06-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |